Plasma fatty acid composition in patients with pancreatic cancer: Correlations to clinical parameters

Nutrition and Cancer

Volumn 64, Issue 7, 2012, Pages 946-955

  MacÁšek, Jaroslav ^a   Vecka, Marek ^a   Žák, Aleš ^a   Urbánek, Miroslav ^a   Krechler, Tomáš ^a   Petruželka, Luboš ^a   Staňková, Barbora ^a   Zeman, Miroslav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LIPID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; FATTY ACID METABOLISM; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PANCREAS CANCER; PHOSPHOLIPID BLOOD LEVEL; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL;

8,11,14-EICOSATRIENOIC ACID; AGED; ALPHA-LINOLENIC ACID; CASE-CONTROL STUDIES; CHOLESTEROL; CZECH REPUBLIC; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; FEMALE; HUMANS; INCIDENCE; LIPID METABOLISM; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL STATUS; PANCREATIC NEOPLASMS; PHOSPHOLIPIDS; TRIGLYCERIDES;

EID: 84867753876     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.716138     Document Type: Article

References (64)

1. Jemal, A, Siegel, R, Xu, J, and, Ward, E. 2010. Cancer Statistics. 2010. CA Cancer J Clin, 60,: 277-300.
2. Institute of Health Information and Statistics of the Czech Republic and Council of the National Oncological Registry of the Czech Republic. 2012. Cancer Incidence 2009, Prague, Czech Republic: ZIS CR and NOR R.
3. Welsch, T, Kleeff, J, Seitz, H K, Bchler, P, Friess, H. 2006. Update on pancreatic cancer and alcohol-associated risk. J Gastroenterol Hepatol, 21,: S69-S75.
4. Maitra, A, and, Hruban, R H. 2008. Pancreatic cancer. Annu Rev Pathol, 3,: 157-188.
5. Koorstra, J-BM, Hustinx, S R, Offerhaus, G JA, and, Maitra, A. 2008. Pancreatic carcinogenesis. Pancreatology, 8,: 110-125.
6. Klapman, J, and, Malafa, M P. 2008. Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control, 15,: 280-287.
7. Vilamachandran, D, Ghaneh, P, Costello, E, and, Neoptolemos, J P. 2004. Genetics and prevention of pancreatic cancer. Cancer Control, 11,: 6-14.
8. Hassan, M M, Bondy, M L, Wolff, R A, Abbruzzese, J L, Vauthey, J N. 2007. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol, 102,: 2696-2707.
9. Krechler, T, Jachymova, M, Pavlikova, M, Vecka, M, Zeman, M. 2009. Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: a pilot study. Neoplasma, 56,: 26-32.
10. Fernandez-del Castillo, C, and, Jimenez, R E. 2002. Pancreatic cancer, cystic pancreatic neoplasms, and other non-endocrine pancreatic tumors. In Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management, 7th ed, Edited by: Feldman, M, Friedman, L S and Sleisinger, M H. 970-987. Philadelphia: WB. Saunders Company.
11. van den Brandt, P A, and, Goldbohm, R A. 2006. Nutrition in the prevention of gastrointestinal cancer. Best Pract Res Clin Gastroenter, 20,: 589-603.
12. Harris, D M, Champaneria, M., and, Go, V LW. 2006. Pancreatic Cancer. In Nutritional Oncology, 2nd ed, Edited by: Heber, D, Blackburn, G L and Milner, J A. 449-473. San Diego, CA: Academic Press.
13. Vigneri, P, Frasca, F, Sciacca, L, Pandini, G, and, Vignery, R. 2009. Diabetes and cancer. Endocr Relat Cancer, 16,: 1103-1123.
14. Riccardi, G, Giacco, R, and, Rivellese, A A. 2004. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr, 23,: 447-456.
15. Semenkovich, C F, Coleman, T, and, Fiedorek, F T Jr. 1995. Human fatty acid synthase mRNA: tissue distribution, genetic mapping, and kinetic decay after glucose deprivation. J Lipid Res, 36,: 1507-1521.
16. Lupu, R, and, Menendez, J A. 2006. Targeting fatty acid synthase in breast and endometrial cancer: an alternative to selective estrogen receptor modulators?. Endocrinology, 147,: 4056-4066.
17. Flowers, M T, and, Ntambi, J M. 2008. Role of Stearoyl-Coenzyme A desaturase in regulating lipid metabolism. Curr Opin Lipidol, 19,: 248-256.
18. Howe, G R, and, Burch, J D. 1996. Nutrition and pancreatic cancer. Cancer Causes Control, 7,: 69-82.
19. Stolzenberg-Solomon, R Z, Pietinen, P, Taylor, P R, Virtamo, J, and, Albanes, D. 2002. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol, 155,: 783-792.
20. Thiebaut, A CM, Jiao, L, Silverman, D T, Gross, A J, Thompson, F E. 2009. Dietary fatty acids and pancreatic cancer in the NIH-AARP Diet and Health Study. J Natl Cancer Inst, 101,: 1001-1011.
21. Nkondjock, A, Krewski, D, Johnson, K C, Ghadirian, P, and the Canadian Cancer Registries Epidemiology Research Group. 2005. Specific fatty acid intake and the risk of pancreatic cancer in Canada. Brit J Cancer, 92,: 971-977.
22. Berquin, I M, Edwards, I J, and, Chen, Y Q. 2008. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Letters, 269,: 363-377.
23. Gerber, M, Thiébaut, A, Astorg, P, Clavel-Chapelon, F, and, Combe, N. 2005. Dietary fat, fatty acid composition and risk of cancer. Eur J Lipid Sci Technol, 107,: 540-559.
24. Wendel, M, and, Heller, A R. 2009. Anticancer actions of omega-3 fatty acidscurrent state and future perspectives. Anticancer Agents Med Chem, 9,: 457-470.
25. Lochman, T, Roche, A, and, Martorel, R. 1989. Standardization of anthropometric measurements, Champaign, IL: Human Kinetics Publishers.
26. Durnin, J V, and, Womersley, J. 1974. Body fat assessed from the total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 71years. Br J Nutr, 32,: 7-97.
27. Kuneová, M, Hainer, V, Tvrzická, E, Phinney, S D, tich, V, Pazková, J. 2002. Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids, 37,: 27-32.
28. McMillan, D C. 2009. Systemic inflammation, nutritional status and in patients with cancer. Curr Opin Clin Nutr Metab Care, 12,: 223-226.
29. Matthews, D R, Hosker, J P, Rudenski, A S, Naylor, B A, Treacher, D F. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28,: 412-419.
30. Fleming, I D, Cooper, J S, and, Henson, D E. 1997. AJCC: Cancer Staging Manual,., 5th ed, New York: Lippincott-Raven, Philadephia.
31. Tvrzická, E, Vecka, M, Staková, B, and, ák, A. 2002. Analysis of fatty acids in plasma lipoproteins by gas chromatography-flame ionisation detection: Quantitative aspects. Anal Chim Acta, 465,: 337-350.
32. Warensj, E, Rosell, M, Hellenius, M-L, Vessby, B, De Faire, U. 2009. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids in Health and Disease, 8,: 37 doi: 10.1186/1476-511X-8-37
33. Ahotupa, M, Ruutu, M, and, Mntyl, E. 1996. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem, 29,: 139-144.
34. Tisdale, M J. 2005. Molecular pathways leading to cancer cachexia. Physiology, 20,: 340-348.
35. Bing, C. 2011. Lipid mobilization in cachexia: mechanism and mediators. Curr Opin Support Palliat Care, 5,: 356-360.
36. Batista, M L Jr, Peres, S B, McDonald, M E, Alcantra, P SM, Olivan, M, Otoch, J P, Farmer, S R, and, Seelaender, M. 2012. Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors. Cytokine, 57,: 9-16.
37. Cowey, S, and, Hardy, R W. 2006. The metabolic syndrome: a high-risk state for cancer ?. Am J Pathol, 169,: 1505-1522.
38. Calle, E E, and, Kaaks, R. 2004. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer, 4,: 579-591.
39. La Vecchia, C, Negri, E, Franceschi, S, DAvanzo, B, and, Boyle, P. 1994. A case control study of diabetes mellitus and cancer risk. Br J Cancer, 70,: 950-953.
40. Malenfant, P, Joanisse, D R, Thériault, R, Goodpaster, B H, Kelley, D E. 2001. Fat content in individual muscle fibers of lean and obese subjects. Int J Obes, 25,: 1316-1321.
41. Stephens, N A, Skipworth, R JE, MacDonald, A J, Greig, C A, Ross, J A. 2011. Intramyocellular lipid droplets increase with progression of cachexia in cancer patients. J Cachexia Sarcopenia Muscle, 2,: 111-117.
42. Fouladiun, M, Krner, U, Bosaeus, I, Daneryd, P, Hyltander, A. 2005. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care-correlations with food intake, metabolism, exercise capacity, and hormones. Cancer, 103,: 2189-2198.
43. ák, A, Tvrzická, E, Vecka, M, Jáchymová, M, Duffková, L. 2007. Severity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in men. Tohoku J Exp Med, 212,: 359-371.
44. Jeppesen, P B, Christensen, M S, Hoy, C E, and, Mortensen, P B. 1997. Essential fatty acid deficiency in patients with servere fat malabsorption. Am J Clin Nutr, 65,: 837-843.
45. Simon, J A, Fong, J, Bernert, J T, and, Browner, W S. 1996. Relation of smoking and alcohol consumption to serum fatty acids. Am J Epidemiol, 144,: 325-334.
46. Pratt, V C, Watanabe, S, Bruera, E, Mackey, J, Clandinin, M T. 2002. Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation. Br J Cancer, 87,: 1370-1378.
47. ák, A, Jáchymová, M, Tvrzická, E, Vecka, M, Duffková, L. 2008. The influence of polymorphisms of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress. J Nutr Biochem, 19,: 634-641.
48. Zeman, M, Vecka, M, Jáchymová, M, Jirák, R, Tvrzická, E. 2009. Fatty acid CoA ligase-4 gene polymorphism influences fatty acid metabolism in metabolic syndrome, but not in depression. Tohoku J Exp Med, 217,: 287-293.
49. Neoptolemos, J P, Clayton, H, Heagerty, A M, Nicholson, M J, Johnson, B. 1988. Dietary fat in relation to fatty acid composition of red cells and adipose tissue in colorectal cancer. Br J Cancer, 58,: 575-579.
50. Lissner, L, Kroon, U B, Bjrntorp, P, Blosk, S, Wilhelmsen, L. 1993. Adipose tissue fatty acids and dietary fat sources in relation to endometrial cancer: a retrospective study of cases in remission, and population-based controls. Acta Obstet Gynecol Scand, 72,: 481-487.
51. Paillard, F, Catheline, D, Le Duff, F, Bouriel, M, Deugnier, Y. 2008. Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis, 18,: 436-440.
52. Scaglia, N, Chisholm, J W, and, Igal, R A. 2009. Inhibition of stearoyl-CoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS One, 4,: e6812
53. Zuijdgeest-van Leeuwen, S D, van der Heijden, M S, Rietveld, T, van den Berg, J W, Tilanus, H W. 2002. Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin Nutr, 21,: 225-230.
54. Falvella, S F, Pascale, R M, Gariboldi, M, Manenti, G, DeMiglio, M R. 2002. Stearoyl-CoA desaturase 1 (SCD1) gene overexpression i associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Carcinogenesis, 23,: 1933-1936.
55. Morgan-Lappe, S E, Tucker, L A, Huang, X, Zhang, Q, Sarthy, A V. 2007. Identification of Ras-related nuclear protein, targeting protein for Xenopus kinesis-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from and RNAi-based screen. Cancer Res, 67,: 4390-4398.
56. Chajes, V, Hulten, K, van Kappel, A L, Winkvist, A, Kaaks, R. 1999. Fatty acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden. Int J Cancer, 83,: 585-590.
57. Murphy, R A, Wilke, M S, Perrine, M, Pawlowicz, M, Mourtzakis, M. 2010. Loss of adipose tissue and plasma phospholipids: Relationship to survival in advanced cancer patients. Clin Nutr, 29,: 482-487.
58. Krechler, T, Zeman, M, Vecka, M, Macasek, J, Jachymova, M. 2011. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus. Neoplasma, 58,: 58-64.
59. Brown, J M, and, Lawrence, L. 2010. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol, 21,: 192-197.
60. Clarke, S D. 2001. Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr, 131,: 1129-1132.
61. Larsson, S C, Kumlin, M, Ingelman-Sundberg, M, and, Wolk, A. 2004. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr, 79,: 935-945.
62. Murphy, R A, Yeung, E, Mazurak, V C, and, Mourtzakis, M. 2011. Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer, doi: 10.1038/bjc.2011.391
63. Fearon, K CH, von Meyenfeldt, M F, Moses, A GW, van Geenen, R, Roy, A. 2003. Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut, 52,: 1479-1486.
64. Dodesini, A R, Benedini, S, Terruzzi, I, Sereni, L P, and, Luzi, L. 2007. Protein, glucose and lipid metabolism in the cancer cachexia: a preliminary report. Acta Oncol, 46,: 118-120.